about
Actions of N-arachidonyl-glycine in a rat inflammatory pain modelEffect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory painActions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitroNeurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal greyThe tarantula toxin β/δ-TRTX-Pre1a highlights the importance of the S1-S2 voltage-sensor region for sodium channel subtype selectivity.Dissociation of μ- and δ-opioid inhibition of glutamatergic synaptic transmission in superficial dorsal horn.N-arachidonyl-glycine modulates synaptic transmission in superficial dorsal hornMenthol enhances phasic and tonic GABAA receptor-mediated currents in midbrain periaqueductal grey neurons.GABA transporter currents activated by protein kinase A excite midbrain neurons during opioid withdrawal.Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal greyNociceptin, Phe(1)psi-nociceptin(1 - 13), nocistatin and prepronociceptin(154 - 181) effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro.Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1Cellular actions of somatostatin on rat periaqueductal grey neurons in vitro.muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficitsInhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey.Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal grayActions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.Increase by the ORL1 receptor (opioid receptor-like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones.Humanizing mice: catching up with elusive B1 receptors.Stressed-out endogenous cannabinoids relieve pain.Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain modelSumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey.Presynaptic gating of excitation in the dorsal raphe nucleus by GABA.Primary afferents with TRPM8 and TRPA1 profiles target distinct subpopulations of rat superficial dorsal horn neurones.Spinal actions of ω-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model.Descending modulation of pain: the GABA disinhibition hypothesis of analgesia.Targeting the endogenous cannabinoid system to treat neuropathic pain.Nordihydroguaiaretic acid activates hTRPA1 and modulates behavioral responses to noxious cold in mice.Opioid and cannabinoid synergy in a mouse neuropathic pain model.Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses.Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model.Opioids, NSAIDs and 5-lipoxygenase inhibitors act synergistically in brain via arachidonic acid metabolism.Enhancement of opioid inhibition of GABAergic synaptic transmission by cyclo-oxygenase inhibitors in rat periaqueductal grey neurones.Neurobiology Cannabinoids act backwards.Serotonergic modulation of neuronal activity in rat midbrain periaqueductal gray.Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro.Postsynaptic mGluR mediated excitation of neurons in midbrain periaqueductal grey.Upregulation of α1-adrenoceptors on cutaneous nerve fibres after partial sciatic nerve ligation and in complex regional pain syndrome type II.Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes.
P50
Q27498684-4593E374-F362-46E7-BECE-3F4EDA6C5C9BQ28253590-8EEA26CB-3F52-4278-87C9-4DBACB0D630DQ28345171-6BD3BE7F-9075-4452-8EB8-F83C542E13FDQ28580090-C915E14E-7B76-4C7D-BAC1-D3F1AD774E57Q33681373-0841128E-EF68-4DC4-AB89-A6FAD128761AQ34331998-7B911059-D9BD-4B0B-9D6F-290D73CED9E2Q34356128-E74D91C5-35FE-4634-8BB4-05EE783E6206Q34399901-E1A67B67-42FB-4F57-B61C-83623D6425D7Q34554848-209CC14E-0974-43CB-AD1C-7D4C5B6B43D6Q34939968-704CCC80-13D5-479A-8903-7C1061B83CC7Q34953319-177C5A3C-F8D0-4780-B3B3-E0B9919644E7Q35041807-5DD62392-965A-4A62-A112-7B0DFCE0ADF6Q35045328-985E40CD-8846-4297-90C1-06A1376C514BQ35047529-E19F89C3-9834-4A67-8B17-42409C66F787Q35119068-A1693162-FA83-4868-96E3-1CDA6BF526F4Q35130530-47D4CACE-4A9F-4EF5-BBFF-0C255E354D37Q35158147-A210E576-FE13-41D0-9699-966DE0D02557Q35545219-158DD193-C300-469A-8AC5-D4C2A76B10D1Q35873638-021F61AA-256A-4E24-A9CB-47752F3E0B7EQ36026771-7C68CEA4-39AD-4E86-9BA5-D465B062F161Q36346586-A223AAC8-773F-4384-84E3-92B3210D8837Q36744213-7774DAEB-6808-4BB6-A90B-CFB78CFCD13CQ36986892-FA772B13-48FC-435D-B5E7-AF4967B24EF7Q37204074-9B1A08C5-7D49-40AD-931D-FD6DFECD1F5DQ37255327-97FA811B-B8A1-4E1D-BA3D-305E88052583Q37327356-D032A13C-C67A-4A20-B4BD-F0C6228AE3FFQ38234187-6710DDEE-2FEE-46D3-8D60-7B4C5D6D979AQ41990169-61EFCB26-FF17-419A-A5F3-A02F3A095A07Q42106713-51C360A2-83F6-4A6E-834E-CB70981917CFQ42406036-0E003BEC-25F4-41EA-BD34-FA1C265C71B0Q42496848-3DBF3A04-9F98-46CA-9B67-EED4D490DA93Q42707660-0753D883-F459-4A17-A1AE-21C1A5F0EF45Q43070468-CAA57CD2-1A2E-4CBF-BB6F-4F8339049A76Q43182562-E0B8E4B4-B588-4D94-9919-E14D05285755Q43560538-22465555-20AE-4E40-BF7D-966E8B602611Q43798880-410FB2D8-7E3E-43E9-9866-04FEAC37D89DQ44121194-C9DAFBAD-1411-457A-A90C-9F0A74EF4CB4Q44225144-DEDD76D7-D56F-40EA-A191-2D392DCBB5B0Q44229063-5F779E16-E58E-4315-A8A5-D3AC6A16B3CEQ44251944-7D4154B3-0F46-49D7-BC77-1C045CB7ED63
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Christopher W Vaughan
@ast
Christopher W Vaughan
@en
Christopher W Vaughan
@es
Christopher W Vaughan
@nl
Christopher W Vaughan
@sl
type
label
Christopher W Vaughan
@ast
Christopher W Vaughan
@en
Christopher W Vaughan
@es
Christopher W Vaughan
@nl
Christopher W Vaughan
@sl
altLabel
Christopher Vaughan
@en
prefLabel
Christopher W Vaughan
@ast
Christopher W Vaughan
@en
Christopher W Vaughan
@es
Christopher W Vaughan
@nl
Christopher W Vaughan
@sl
P106
P21
P31
P496
0000-0003-4314-7689